Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency
Sponsor: Ascendis Pharma Endocrinology Division A/S
Summary
This was a phase 3 open-label multicenter extension study designed to evaluate the long-term safety and efficacy of Lonapegsomatropin administered once-weekly. The study participants were adults (males and females) with confirmed growth hormone deficiency (GHD) having completed the treatment period in study TCH-306 (foresiGHt; NCT04615273).
Official title: A Multicenter, Open-Label, Extension Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency
Key Details
Gender
All
Age Range
23 Years - 81 Years
Study Type
INTERVENTIONAL
Enrollment
220
Start Date
2021-12-16
Completion Date
2024-12-23
Last Updated
2026-07-07
Healthy Volunteers
No
Interventions
Lonapegsomatropin
Study participants were individually dosed with subcutaneous injection of Lonapegsomatropin once-weekly for 52 weeks.
Locations (85)
Ascendis Pharma Investigational Site
Phoenix, Arizona, United States
Ascendis Pharma Investigational Site
Torrance, California, United States
Ascendis Pharma Investigational Site
Chicago, Illinois, United States
Ascendis Pharma Investigational Site
Indianapolis, Indiana, United States
Ascendis Pharma Investigational Site
Boston, Massachusetts, United States
Ascendis Pharma Investigational Site
Dearborn, Michigan, United States
Ascendis Pharma Investigational Site
Rochester, Minnesota, United States
Ascendis Pharma Investigational Site
St Louis, Missouri, United States
Ascendis Pharma Investigational Site
Las Vegas, Nevada, United States
Ascendis Pharma Investigational Site
Reno, Nevada, United States
Ascendis Pharma Investigational Site
New York, New York, United States
Ascendis Pharma Investigational Site
Portland, Oregon, United States
Ascendis Pharma Investigational Site
Dallas, Texas, United States
Ascendis Pharma Investigational Site
San Antonio, Texas, United States
Ascendis Pharma Investigational Site
Seattle, Washington, United States
Ascendis Pharma Investigational Site
Yerevan, Armenia
Ascendis Pharma Investigational Site
Saint Leonards, New South Wales, Australia
Ascendis Pharma Investigational Site
Sydney, New South Wales, Australia
Ascendis Pharma Investigational Site
Box Hill, Victoria, Australia
Ascendis Pharma Investigational Site
Fitzroy, Victoria, Australia
Ascendis Pharma Investigational Site
Parkville, Victoria, Australia
Ascendis Pharma Investigational Site
Perth, Western Australia, Australia
Ascendis Pharma Investigational Site
Halifax, Nova Scotia, Canada
Ascendis Pharma Investigational Site
Lyon, France
Ascendis Pharma Investigational Site
Marseille, France
Ascendis Pharma Investigational Site
Nantes, France
Ascendis Pharma Investigational Site
Tbilisi, Georgia
Ascendis Pharma Investigational Site
Tbilisi, Georgia
Ascendis Pharma Investigational Site
München, Germany
Ascendis Pharma Investigational Site
Athens, Greece
Ascendis Pharma Investigational Site
Thessaloniki, Greece
Ascendis Pharma Investigational Site
Haifa, Israel
Ascendis Pharma Investigational Site
Petah Tikva, Israel
Ascendis Pharma Investigational Site
Tel Aviv, Israel
Ascendis Pharma Investigational Site
Genova, Italy
Ascendis Pharma Investigational Site
Rome, Italy
Ascendis Pharma Investigational Site
Rome, Italy
Ascendis Pharma Investigational Site
Kobe, Hyōgo, Japan
Ascendis Pharma Investigational Site
Kawasaki, Kanagawa, Japan
Ascendis Pharma Investigational Site
Yokohama, Kanagawa, Japan
Ascendis Pharma Investigational Site
Chiba, Japan
Ascendis Pharma Investigational Site
Fukuoka, Japan
Ascendis Pharma Investigational Site
Ishikawa, Japan
Ascendis Pharma Investigational Site
Kagoshima, Japan
Ascendis Pharma Investigational Site
Kawasaki, Japan
Ascendis Pharma Investigational Site
Kawasaki, Japan
Ascendis Pharma Investigational Site
Kitakyushu, Japan
Ascendis Pharma Investigational Site
Matsumoto, Japan
Ascendis Pharma Investigational Site
Miyakojima, Japan
Ascendis Pharma Investigational Site
Nagakute, Japan
Ascendis Pharma Investigational Site
Nara, Japan
Ascendis Pharma Investigational Site
Okayama, Japan
Ascendis Pharma Investigational Site
Osaka, Japan
Ascendis Pharma Investigational Site
Shizuoka, Japan
Ascendis Pharma Investigational Site
Suita, Japan
Ascendis Pharma Investigational Site
Yamagata, Japan
Ascendis Pharma Investigational Site
Yokohama, Japan
Ascendis Pharma Investigational Site
George Town, Malaysia
Ascendis Pharma Investigational Site
Malacca, Malaysia
Ascendis Pharma Investigational Site
Putrajaya, Malaysia
Ascendis Pharma Investigational Site
Krakow, Poland
Ascendis Pharma Investigational Site
Lodz, Poland
Ascendis Pharma Investigational Site
Warsaw, Poland
Ascendis Pharma Investigational Site
Wroclaw, Poland
Ascendis Pharma Investigational Site
Bucharest, Romania
Ascendis Pharma Investigational Site
Iași, Romania
Ascendis Pharma Investigational Site
Belgrade, Serbia
Ascendis Pharma Investigational Site
Bratislava, Slovakia
Ascendis Pharma Investigational Site
Ľubochňa, Slovakia
Ascendis Pharma Investigational Site
Soeul, South Korea
Ascendis Pharma Investigational Site
Alicante, Spain
Ascendis Pharma Investigational Site
Barcelona, Spain
Ascendis Pharma Investigational Site
Barcelona, Spain
Ascendis Pharma Investigational Site
Seville, Spain
Ascendis Pharma Investigational Site
Ankara, Turkey (Türkiye)
Ascendis Pharma Investigational Site
Antalya, Turkey (Türkiye)
Ascendis Pharma Investigational Site
Aydin, Turkey (Türkiye)
Ascendis Pharma Investigational Site
İzmit, Turkey (Türkiye)
Ascendis Pharma Investigational Site
Kayseri, Turkey (Türkiye)
Ascendis Pharma Investigational Site
Ivano-Frankivsk, Ukraine
Ascendis Pharma Investigational Site
Kyiv, Ukraine
Ascendis Pharma Investigational Site
Kyiv, Ukraine
Ascendis Pharma Investigational Site
Kyiv, Ukraine
Ascendis Pharma Investigational Site
Vinnytsia, Ukraine
Ascendis Pharma Investigational Site
Leeds, United Kingdom